Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Check the spelling in your query or search for a new term.
Site search accepts advanced operators to help refine your query. Learn more.
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
This whitepaper discusses how pharmaceutical companies can maximize the strategic value of formulations data to shorten development times, stay ahead of competition, and position themselves for success.
CAS has completed a project with The National Institute of Industrial Property (INPI) of Brazil for an enhanced examination workflow solution for chemistry patent applications using a unique blend of technology, artificial intelligence, data, and expertise. The new solution reduced application examination times by up to 50%, and helped to reduce their multi-year application backlog.
The world’s most trusted source for scientific information, CAS, leverages new content, technologies, and expertise to advance its life sciences growth initiative.
Drawing on the CAS Content Collection and scientific expertise, CAS Insights offers business and research leaders perspectives on the latest developments across science and technology.
CAS drives Increase in R&D productivity with launch of breakthrough Retrosynthesis Planner in SciFinder-n. This
unites advanced technology with CAS’s unmatched collection of chemical reaction data to increase efficiency of chemical synthesis planning.
This collaboration leverages a tailored CAS Custom Services solution designed on a foundation of specialized CAS technologies, data science, and the CAS Content Collection to empower efficiencies in Dow’s research processes.
Through the CAS Innovation Incubator, CAS offers resources, expertise, and potential funding to early-stage innovators to help boost their science-based ventures.
As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.
CAS collaborated with MIT to accelerate research on chemical synthesis planning. CAS will provide MIT with scientist-curated data for AI training.